Wherever you go, there you are.
Hepatitis C: Achieving Maximum Results Putting Combination Therapy for HCV into Practice
Interferon/ribavirin combination therapy may induce a sustained response in previous nonresponders to interferon monotherapy, including those with normal ALT levels and those with predictors of poor response. Read the rest of this entry »
Early detection is key to effective treatment of hepatitis C. That is why it’s so important to identify people who may be at risk for the disease.
To help you assess your own risk, take our interactive Risk Assessment.
If you suspect that you have hepatitis or think you have been in contact with an infected person or a contaminated object, consult your doctor as soon as possible.